Together Pharma Ltd (TLV: TGTR)
Israel
· Delayed Price · Currency is ILS · Price in ILA522.50
+12.60 (2.47%)
Nov 19, 2024, 5:24 PM IDT
Together Pharma Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -2.56 | -4.32 | -33.52 | -13.78 | 7.15 | -15.28 | Upgrade
|
| Depreciation & Amortization | 4.99 | 6.51 | 6 | 5.48 | 4.24 | 1.54 | Upgrade
|
| Other Amortization | 13.12 | 17.34 | 14.3 | 12.25 | 9.47 | 6.41 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0 | 0.04 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.22 | -0.22 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.27 | 0.47 | 0 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | 1.45 | 4.1 | 6.75 | Upgrade
|
| Other Operating Activities | 6.63 | 4.59 | -0.95 | -13.36 | -3.58 | -6.97 | Upgrade
|
| Change in Accounts Receivable | -3.26 | -4.28 | -7.44 | 0.42 | -1.34 | - | Upgrade
|
| Change in Inventory | -15.03 | -10.5 | 3.4 | -9.8 | -33.18 | -4.79 | Upgrade
|
| Change in Accounts Payable | 8.67 | 4.41 | 2.96 | -1.15 | 2.89 | -2.86 | Upgrade
|
| Change in Other Net Operating Assets | 0.04 | 0.82 | 1.51 | -0.16 | 0.5 | 8.38 | Upgrade
|
| Operating Cash Flow | 12.66 | 14.83 | -13.73 | -18.64 | -9.7 | -6.83 | Upgrade
|
| Capital Expenditures | -1.83 | -0.87 | -0.33 | -1.53 | -13.75 | -8.05 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.01 | 0.12 | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -4 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.15 | -0.15 | -0.41 | -0.1 | -5.6 | -8.25 | Upgrade
|
| Other Investing Activities | -0.56 | -0.6 | 33.79 | -27.23 | -8.66 | - | Upgrade
|
| Investing Cash Flow | -2.09 | -1.62 | 33.05 | -28.85 | -27.9 | -20.31 | Upgrade
|
| Long-Term Debt Issued | - | 78.06 | 50.35 | 38.92 | 37.34 | 27.92 | Upgrade
|
| Total Debt Issued | 83.42 | 78.06 | 50.35 | 38.92 | 37.34 | 27.92 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.04 | -0.2 | Upgrade
|
| Long-Term Debt Repaid | - | -92.28 | -80.22 | -11.84 | -6.36 | -23.46 | Upgrade
|
| Total Debt Repaid | -89.65 | -92.28 | -80.22 | -11.84 | -6.39 | -23.66 | Upgrade
|
| Net Debt Issued (Repaid) | -6.22 | -14.22 | -29.87 | 27.09 | 30.94 | 4.25 | Upgrade
|
| Issuance of Common Stock | - | - | 11.53 | 24.73 | 10.08 | 24.15 | Upgrade
|
| Other Financing Activities | - | -0.7 | -0.8 | -2.97 | -0.8 | -0.36 | Upgrade
|
| Financing Cash Flow | -6.22 | -14.92 | -19.14 | 48.84 | 40.23 | 28.04 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | 0 | 0.03 | -0.01 | -0.01 | - | Upgrade
|
| Net Cash Flow | 4.33 | -1.7 | 0.2 | 1.34 | 2.62 | 0.9 | Upgrade
|
| Free Cash Flow | 10.82 | 13.97 | -14.07 | -20.17 | -23.46 | -14.89 | Upgrade
|
| Free Cash Flow Margin | 11.29% | 15.35% | -45.04% | -167.75% | -208.99% | - | Upgrade
|
| Free Cash Flow Per Share | 1.09 | 1.59 | -1.73 | -2.94 | -4.07 | -2.97 | Upgrade
|
| Cash Interest Paid | 3.51 | 4.44 | 2.23 | 2.74 | 1.08 | 0.02 | Upgrade
|
| Levered Free Cash Flow | 20 | 16.97 | 29.26 | -38.12 | -30.36 | -10.31 | Upgrade
|
| Unlevered Free Cash Flow | 18.17 | 11.36 | 25.6 | -41.12 | -32.42 | -12.49 | Upgrade
|
| Change in Net Working Capital | -0.36 | 7.94 | -32.7 | 39.26 | 31.79 | -5.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.